Corporis Medical develops smart tools that make surgeries safer and more effective. The company’s flagship product — Laprixa — is the world’s smallest tissue blood pressure device, providing surgeons with an objective assessment of bowel tissue’s healing capacity during surgery. Laprixa helps them make better-informed decisions, potentially preventing complications.
Corporis Medical also developed Mediclose, a sterile disposable device for suturing trocar-induced wounds after laparoscopic surgery. Mediclose is unique in that it automatically closes incisions from inside out so there are no exposed needles or any anchors left behind. That reduces the risk of trocar-site incisional hernias and other complications related to laparoscopic procedures.
Brightlands – Corporis Medical Closes €4M Series B Financing Round
Brightlands – Better for the Patient, More Efficient for the Surgeon
Economische Samenwerking Zuid-Limburg – Medtech Companies Invest in the Smallest Blood Pressure Monitor
Health~Holland – Corporis Medical Raises €2 Million for Innovative Surgical Devices
Innovation Origins – Laprixa: The Smallest Blood Pressure Monitor in the World Improves Wound Healing
Silicon Canals – Dutch-based Corporis Medical Raises €4M to Develop and Commercialize Medical Devices for Minimally Invasive Surgery
EIT Health – Quality Label
European Innovation Council – Seal of Excellence
MIT South – Mediclose: Towards Improved Abdominal Surgery
Netherlands Enterprise Agency – Laprixa: The Smallest Organ Blood Pressure Measurement Device in the World
Every year, American entrepreneurs start more than half a million companies. More than 90% of them will fail, with only 200 ever passing $100 million in revenue. At Unorthodox Ventures, we know how to reach $300 million. Jump in with us.
